House of Representatives · 20th Congress

HB08896

AN ACT STRENGTHENING THE REGULATORY SYSTEM IN THE COUNTRY TO COMBAT COUNTERFEIT PHARMACEUTICAL PRODUCTS, DECLARING THE MANUFACTURE, IMPORTATION, DISTRIBUTION, SALE OR OFFER FOR SALE, OR POSSESSION OF COUNTERFEIT PHARMACEUTICAL PRODUCTS AS AN OFFENSE INVOLVING ECONOMIC SABOTAGE, PROVIDING PENALTIES FOR VIOLATIONS THEREOF, REPEALING FOR THE PURPOSE REPUBLIC ACT NO. 8203, OTHERWISE KNOWN AS THE "SPECIAL LAW ON COUNTERFEIT DRUGS"

Status: Pending with the Committee on HEALTH since 2026-05-05 · Filed 2026-04-21 · Committee: HEALTH

Official documents

Recorded votes

No recorded vote for this bill in the official journals we have processed so far. That does not mean no vote took place.

Principal authors (4)

Acidre, Jude A. · Representative, TINGOG
Romualdez, Andrew Julian K. · Representative, TINGOG
Romualdez, Ferdinand Martin G. · Representative, Leyte, 1st District
Romualdez, Yedda Marie K. · Representative, TINGOG

As listed in the chamber's official author records.

Sources: House Journals (docs.congress.hrep.online), BatasWatch bill and author index (CC0), which mirrors official House and Senate records.